TLDRs;
- HUL sells Nutritionalab stake to focus on high-growth premium brands in India.
- Portfolio reshuffle emphasizes Beauty & Wellbeing, Home Care liquids investments.
- Quarterly profits pressured by competition, price cuts, and higher acquisition costs.
- Investors watch if premium strategy can drive revenue without margin erosion.
Mumbai, March 6, 2026 – Shares of Unilever (UL) saw a modest dip on Friday following the announcement that Hindustan Unilever, the company’s Indian arm, has completed the sale of its entire 19.8% stake in Nutritionalab Private Limited.
The divestment, valued at roughly 307 crore rupees (~3.07 billion rupees), marks a strategic pivot as the consumer goods giant refocuses on premium, high-growth segments.
HUL Exits Nutritionalab
The exit from Nutritionalab comes as part of a broader “portfolio transformation,” according to HUL’s recent filings. Earlier this month, the company finalized the sale alongside the acquisition of the remaining 49% stake in OZiva, signaling a clear decision to concentrate resources on fewer, but bigger, growth opportunities.
During a recent earnings call, finance chief Niranjan Gupta emphasized that the Nutritionalab sale was not a reflection of its performance. Instead, HUL intends to double down on OZiva and other premium brands poised for accelerated growth in the Indian market. CEO Priya Nair highlighted that this strategic move is designed to “scale our brands and create categories of the future.”
Premium Push Drives Investment
HUL is backing its premium push with significant capital allocation. On February 18, the company announced plans to invest up to 2,000 crore rupees over the next two years to enhance production capabilities in Beauty & Wellbeing and Home Care liquids. These categories are viewed as key growth drivers for both India and the United States, where the company expects robust demand despite softening sales in other regions.
CEO Fernando Fernandez has reiterated that the focus on personal care, beauty, and wellbeing represents the backbone of the company’s long-term strategy. Analysts note that this approach mirrors a broader trend among major consumer goods players, including Reckitt and Nestle, who are similarly consolidating portfolios around higher-margin, faster-growing brands.
Market Pressures Challenge Margins
Despite the strategic clarity, Unilever’s recent quarterly results highlighted challenges for margins. HUL reported a 15% decline in profits due to competitive pricing pressures, increased acquisition costs, and fewer product launches. Distribution-led growth partially offset these pressures, with a reported 4% volume increase cited as a modest bright spot.
Independent consultants point to the rise of direct-to-consumer (D2C) brands in India, which are reshaping consumer habits and compelling established players like HUL to accelerate portfolio rotation. Analysts note that the premium strategy is ambitious but carries execution risk, particularly in balancing revenue growth with margin protection.
Investors Watch Premium Strategy
The market’s slight reaction reflects cautious optimism. While the Nutritionalab exit frees resources for high-potential brands, investors are evaluating whether HUL’s aggressive premium strategy can translate into sustainable earnings.
With the company emphasizing efficiency, decisiveness in portfolio decisions, and targeted investment in beauty and wellbeing, the next few quarters will be closely monitored for margin stability and revenue growth.
As consumer tastes continue to evolve and competition intensifies, Unilever’s ability to capitalize on its premium bets will likely determine the trajectory of UL stock in India and globally.





